Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)
Read More
Tags:
CA,
Leukemia,
new research funding,
cancer research,
San Diego,
SDVS,
UCSD,
Biotechnology Vendor Showcase,
cancer research funding,
2018,
AML Research,
Acute Myeloid Leukemia
.jpg?width=293&name=1024px-Cytomegalovirus_infection_(3785988653).jpg "Cytomegalovirus")
Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.
Read More
Tags:
CA,
new research funding,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
NIH funding,
2017,
cytomegalovirus
A team of biochemists at UCLA have created a novel system of converting glucose into highly useful chemical compounds, such as those needed to create biofuels and pharmaceuticals. Previous research endeavors relied on using cells to convert sugar into desired compounds. This has been difficult to achieve because cells would rather use sugar for their own natural uses, such as building proteins and cell walls. The UCLA biochemists have recently developed a way to achieve the conversion of glucose into desired compounds- without using cells.
Read More
Tags:
CA,
University of California Los Angeles,
Los Angeles,
Biochemistry,
chemistry research,
Chemistry,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
2016,
Western,
glucose
The University of California, San Francisco is one of the most well-funded research institutions in the country, comprised of hundreds of life scientists conducting cutting-edge research who continuously publish important research results. Thanks to a generous donation, the university will be expanding its research space over the next few years.
(Image courtesy of Payton Chung via Wikimedia Commons)
Sandy and Joan Weill have recently announced a donation of $185 million to UCSF to create a new neuroscience institute on the UCSF Mission Bay campus, called the Weill Institute for Neurosciences. The institute will be housed in a soon-to-be-built $316 million facility, providing 270,000 square feet for research and outpatient services where medical practitioners and researchers can collaborate on projects.
Read More
Tags:
CA,
Southwest,
Neuroscience,
SFVS,
Biotechnology Vendor Showcase,
UCSF,
new Building,
new funding,
UC San Francisco Parnassus,
funding news,
2016,
Weill Institute for Neurosciences,
Sandy and Joan Weill
A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.
Read More
Tags:
CA,
University of California Los Angeles,
Stem Cells,
Los Angeles,
genetic engineering,
UCLA,
Biotechnology Vendor Showcase,
new funding,
cancer research funding,
tumor cells
When vital organs in the body, such as the lungs, begin to fail, an organ transplant can be a solution to the problem. However, receiving a transplant may have its own complications, such as the body rejecting its new organ.
Now, thanks to a generous donation of $1 million dollars from Michael and Linda Keston, researchers from the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine will be able to continue studying lung disease and the organ rejection commonly following a transplant.
Read More
Tags:
CA,
University of California Los Angeles,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
new funding,
2016,
Lung Disease,
organ transplant,
organ rejection
Since HIV/AIDS emerged as a global health problem in the 1980's, researchers have been diligently working to create new treatments and vaccines for the disease. Currently, there is no cure for the disease, and treatments can only suppress it. Because of its severity and broad reach, scientists around the world receive substantial funding each year to study this virus in order to gain a more thorough understanding and better combat it. Now, thanks to an award from the Foundation for AIDS Research (amfAR), researchers at the University of California, San Francisco will be able to study the virus in a new $20 million institute, located on the Mission Bay campus, for the next five years.
Tags:
CA,
University of California San Francisco,
HIV,
AIDS Research,
Southwest,
San Francisco,
SFVS,
Biotechnology Vendor Showcase,
UCSF,
UCSF Mission Bay,
New research center,
2016
The National Institutes of Health has awarded $30 million in grants for the development of the 4D Nucleome Program at University of California, San Diego. The $120 million NIH project comprises six separate initiatives, with three of the initiatives involving UCSD researchers.
Read More
Tags:
CA,
University of California San Diego,
California,
SD,
Neuroscience,
San Diego,
SDVS,
UCSD,
Research Funding,
UC San Diego,
Biotechnology Vendor Showcase,
NIH funding,
Southwest Region,
2016
During pregnancy, much of a fetus’ development is contingent on the condition and function of the placenta. It is responsible for the transmission of substances from mother to child that are critical to early development, including blood, oxygen and nutrients, without which the fetus could not exist. Sometimes, however, environmental effects can cause deficiencies in the placenta, which can lead to harmful side effects such as preterm birth or even death.
Read More
Tags:
CA,
University of California Los Angeles,
Medical Research,
California,
Los Angeles,
Development,
UCLA,
Biotechnology Vendor Showcase,
NIH funding,
NIH award,
Southwest Region,
2016,
best science tradeshows,
pollution,
pregnancy
A recent study conducted at University of California, San Diego has found that bacterial communities are more cooperative than was previously thought.
Read More
Tags:
CA,
University of California San Diego,
California,
Biology,
Molecular Biology,
2015,
San Diego,
SDVS,
UCSD,
Life Sciences,
UC San Diego,
biotech,
Biotechnology Vendor Showcase,
NIH grant,
Southwest Region,
NSF grant
